Education
About Us
Working with TipRanks
Follow Us
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -3.40M | $ -657.93K | $ -325.39K | $ -1.06M | $ -2.75M |
| EBITDA | $ 378.84K | $ -657.93K | $ -325.39K | $ -1.06M | $ -2.75M |
| Net Income | $ -3.03M | $ 12.11M | $ -313.47K | $ -1.06M | $ -2.72M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.84M | $ 11.95M | $ 30.63K | $ 75.06K | $ 803.82K |
| Total Assets | $ 8.95M | $ 11.98M | $ 58.78K | $ 131.76K | $ 899.97K |
| Total Debt | $ 0.00 | $ 411.00K | $ 231.00K | $ 96.60K | $ 0.00 |
| Net Debt | $ -8.84M | $ -11.54M | $ 200.37K | $ 21.54K | $ -803.82K |
| Total Liabilities | $ 3.67M | $ 3.68M | $ 3.68M | $ 3.49M | $ 3.43M |
| Stockholders' Equity | $ 5.28M | $ 8.30M | $ -3.62M | $ -3.36M | $ -2.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.70M | $ 11.74M | $ -220.43K | $ -825.36K | $ -2.71M |
| Operating Cash Flow | $ -2.70M | $ 11.74M | $ -220.43K | $ -825.36K | $ -2.71M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -411.00K | $ 180.00K | $ 176.00K | $ 96.60K | $ 2.40M |